Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Jun 2012 11:31

RNS Number : 8748F
Oxford Biomedica PLC
21 June 2012
 



Financial Services Authority

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Oxford Biomedica Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General Group Plc (L&G)

4. Full name of shareholder(s)  (if different from 3.):

N/A

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

 

19 June 2012

6. Date on which issuer notified:

20 June 2012

7. Threshold(s) that is/are crossed orreached:

 

L&G (Below 3%)

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

Ordinary 1p

 21,605,215

 

(As on 16/06/2010)

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

Below 3%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)

Legal & General Investment Management Limited (Indirect) (LGIM)

Legal & General Group Plc (Direct) (L&G) (Below 3% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of  944,875,557

 

14. Contact name:

Paul Toon (LGIM)

15. Contact telephone number:

020 3124 3854

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAURRUKANUAR
Date   Source Headline
3rd Mar 20157:00 amRNSTotal Voting Rights
23rd Feb 20153:36 pmRNSChief Secretary to the Treasury visits OXB
16th Feb 201511:41 amRNSChange of Registered Address
30th Jan 201510:47 amRNSTotal Voting Rights
28th Jan 20154:40 pmRNSSecond Price Monitoring Extn
28th Jan 20154:35 pmRNSPrice Monitoring Extension
31st Dec 20147:00 amRNSBLOCK LISTING RETURN
31st Dec 20147:00 amRNSTotal Voting Rights
18th Dec 20142:45 pmRNSDirector's Share Purchase.
18th Dec 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES.
16th Dec 20143:50 pmRNSDirector PDMR Shareholding
16th Dec 20143:50 pmRNSNotification Of Major Interest In Shares
1st Dec 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
28th Nov 20147:00 amRNSTotal Voting Rights
26th Nov 20147:00 amRNSDirector Dealings
3rd Nov 20147:00 amRNSInterim Management Statement
31st Oct 20147:00 amRNSTotal Voting Rights
17th Oct 20149:27 amRNSDirector's Interest in Share Options
17th Oct 20149:10 amRNSHolding(s) in Company
16th Oct 20144:52 pmRNSDirectorate Change
15th Oct 20145:05 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSOxford BioMedica plc Director's Share Purchase
13th Oct 20147:00 amRNSOxford BioMedica Acquires Windrush Court Office
10th Oct 20147:41 amRNSAdditional Listing
10th Oct 20147:00 amRNSSecond major agreement with Novartis
28th Aug 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSPaul Blake Appointed as Chief Development Officer
7th Aug 20147:00 amRNSNotice of Results
25th Jul 20149:48 amRNSBlock listing Application
1st Jul 201410:55 amRNSOxford BioMedica plc Director's Share Purchase
30th Jun 20147:00 amRNSTotal Voting Rights Update
23rd Jun 20147:00 amRNSDirectors' Interest in Share Options
20th Jun 20142:38 pmRNSPiper Jaffray GenomeRx Symposium in New York
19th Jun 20149:50 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:01 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Jun 20147:00 amRNSGRANT OF AWARDS
18th Jun 201411:30 amRNSLoan Repayment in Full
18th Jun 20149:36 amRNSHolding(s) in Company
18th Jun 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Jun 201412:29 pmRNSRESULT OF GENERAL MEETING AND DIRECTORS DEALING
16th Jun 20147:00 amRNSResults of firm fundraising and open offer
3rd Jun 201412:34 pmRNSResult of AGM
29th May 20144:52 pmRNSNotice of posting of prospectus
29th May 20147:00 amRNSFundraising and Open Offer
22nd May 20149:22 amRNSDirector Declaration
13th May 20147:00 amRNSInterim Management Statement
2nd May 20144:57 pmRNS2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30th Apr 20147:00 amRNS£2.2 Million Grant Received from TSB
29th Apr 20147:00 amRNSOxford BioMedica provides update on RetinoStat®
10th Apr 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.